pramlintide side effects FAQ

Adult dosage Injectable solution

If your medical doctor is using this medicine to treat your pain, your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor, health care provider, or pharmacist first.

Pramlintide is a prescription medication used to treat the symptoms of Type 1 and Type 2 Diabetes.

Serious side effects of Symlin include severe hypoglycemia when used with insulin. Nausea decreases with continued administration of pramlintide and is less severe when pramlintide is slowly increased to the desired dose. When used with insulin, especially in patients with type 1 diabetes, severe hypoglycemia may occur. If severe hypoglycemia occurs, it usually manifests within 3 hours after receiving pramlintide.

Symlin (pramlintide) is an anti-diabetic medication that lowers the level of sugar (glucose) in blood used to treat type 1 and type 2 diabetes. Symlin is a synthetic (man-made) hormone that resembles human amylin. Amylin is a hormone that is produced by the pancreas and released into the blood after meals where it helps the body to regulate levels of blood glucose. Amylin acts in several ways to control blood glucose. It slows the rate at which food (including glucose) is absorbed from the intestine. Amylin reduces the production of glucose by the liver by inhibiting the action of glucagon, a hormone produced by the pancreas that stimulates the production of glucose by the liver. Amylin also reduces appetite. In studies, Symlin-treated patients achieved lower blood glucose levels and experienced weight loss. Drug interactions of Symlin include other drugs that slow down the intestine (for example, atropine) or slow the absorption of food (for example, acarbose).

Common side effects of Symlin include